First-Line Pembrolizumab Plus Chemotherapy for Advanced Biliary Tract Cancer: China Subgroup Analysis of the Randomized Phase 3 KEYNOTE-966 Study.

Detalles Bibliográficos
Publicado en:	Advances in Therapy Vol. 43; no. 9; pp. 3871 - 3886
Autores principales:	Ren, Zhenggang, Liang, Tingbo, Gu, Shanzhi, Gou, Hongfeng, Peng, Chuang, Pan, Yueyin, Song, Tianqiang, Su, Haichuan, Cao, Ke, Liang, Houjie, Ying, Jieer, Geng, Zhimin, Yu, Wenchang, Zhao, Haitao, Bai, Yuxian, Hao, Chunyi, Mao, Yimin, Li, Wei, Wang, Lu, Li, Dongliang
Formato:	Journal Article
Publicado:	Springer Nature Sep2026
Acceso en línea:	Ver este registro en EBSCOhost

Descripción
Descripción no disponible.